首页> 外国专利> MICROENCAPSULATION OF LIVING CELLS IN COVALENTLY CROSSLINKED ALGINATE-POLY-L-LYSINE-ALGINATE MEMBRANES

MICROENCAPSULATION OF LIVING CELLS IN COVALENTLY CROSSLINKED ALGINATE-POLY-L-LYSINE-ALGINATE MEMBRANES

机译:均交联的藻酸盐-聚-L-赖氨酸-藻酸盐膜中活细胞的微囊化

摘要

Immunoisolation of cells in semipermeable membranes has been proposed as ameans to prevent their immune destruction following transplantation[1, 2].However,several fundamental issues remain to be addressed before considering clinicalapplicationof this method. One such issue is the resistance of microcapsules to chemicalandmechanical degradation. Strong microcapsules will obviously increase thedurability ofthe transplant. It is also likely to improve long-term biocompatibility ofmicrocapsules,since a strong pericapsular reaction always develops around broken or damagedcapsules[3, 4]. Moreover, the strength and durability of microcapsule membranearecritical issues for the transplantation of virus-transfected bioengineeredcells. Thesevirus-transfected bioengineered cells potentially include insulin-producingcells as well as cellsproducing molecules, which promote islet cellsurvival/replication/transdifferentiation orinsure islet and microcapsule immunoprotection. Finally, considering thelimited supplyof human islets, the most promising approach to .beta.-cell replacement is thetransdifferentiation of stem cells into islets[5] (not necessarily embryonicstem cells,which arise controversy, but stem cells of many other origins, includingautologous cells).Note that even autologous cells would require immunoprotection against therecurrenceof the autoimmune process. The major concern related to this approach is therisk ofmalignant transformation of immature stem cells. Microcapsules that can hardlybe destroyed in conditions compatible with life would provide a safe method oftransplanting stem cell derived cells, bioengineered cells or immortalizedcells.Complexation between alginate and polycations such as poly-L-lysine(PLL) isthemost widely used method to microencapsulate cells[2]. Microcapsules areconstructedby a simple three steps procedure. First, the calls are entrapped in a beadformed bythe ionic cross-linking of alginate by a divalent ration such as calcium[6].The secondstep comprises coating the alginate beads with a polycation such as PLL, whichformsa peripheral membrane ensuring a good control of the molecular weight cut-offandincreasing membrane stability. Finally, the third step consists to coat themicrocapsules with a dilute alginate solution for insuring biocompatibility.The twolatter reactions rely on the ionic interactions between the polyanionicalginate and thepolycationic polymer of lysine[7, 8].In order to improve microcapsule strength, we[9] and others[7, 8, 10, 11],haveevaluated the effect on microcapsule strength of modulating intrinsicparameters PLLmolecular weight, concentration and incubation time and the mannuronicacid/guluronicacid ratio of alginate. The formation of neutral capsules by the introductionof a newcoating agent[12] has also been investigated. Following these experiments,tighterbinding between PLL and alginate was obtained. Nevertheless, poly-L-lysinestillcompetes with other positively charged molecules in the environment to bind tothealginate beads. A prolonged incubation in solutions with high concentrationsof Ca2+ orSr2+ has showed a displacement of the alginate-poly-L-lysine bounds[13, 14].In addition,Thu et al. have observed the progressive loss of the external sheet ofalginate frommicrocapsules within days or weeks[7].To prevent this competition with charged molecules in the environment, a newconcept has been proposed: the introduction of covalent links into themembrane of themicrocapsule[15-17]. Covalent links are known to be more stable thanelectrostaticinteractions. The challenge is that most methods to create or to break acovalent link areincompatible with the survival of living cells. The objective of the presentwork was todevelop and validate a method, compatible with encapsulated cell survival, tocreate acovalent link between the PLL layer and both alginate from the microcapsulecore andfrom the outer sheet. It would be unlikely that such a microcapsules would bedestroyedin conditions found in the living body.Here we show that it is possible to microencapsulate living cells in membranescomposed of covalently linked alginate-PLL-alginate membranes, withoutaffecting cellviability. The formation of a covalent link between PLL and alginate from boththealginate core and the outer alginate shoes considerably increased microcapsuleresistanceto chemical and mechanical stress. Standard APA microcapsules dissolved within45seconds when they were incubated in an alkaline solution whereas covalentlylinked APAmicrocapsules remained unaltered after two years in the same alkaline solutionCovalently linked microcapsules were 22 times more resistant than standardmicrocapsules when they were submitted to a mechanical stress. The process isbased onthe chemical derivation of poly-L-lysine (PLL) with a photoactivatableheterobifunctional cross-linker, N-5-Azido-2-nitrobenzoyloxysuccinimide (ANB-NOS),which is able to covalently bind PLL to alginate when energized by UVA lightillumination[18, 19]. The N-hydroxysuccinimid of the cross-linked was fistcovalentlylinked to PLL in conditions that would damage living cells, but before thecolts areinvolved in the procedure. Then islet cells encapsulated in calcium alginatemicrocapsules were incubated with the arose-linker derived PLL, than inalginate again toform the outer biocompatible sheet. When the preparation is illuminated with aUVAlamp the photoactivatable residue reacts with the phenyl azide residue onalginatecreating a covalent link between PLL and alginate. The latter reaction is notharmful forliving cells. All reactions involving the crosslinker-derived PLL wereperformed in a darkroom, until UVA illumination, to prevent activation of the photoactivatableresidue.We, herein, present a proof that a covalent link was formed providingconsiderableimprovement of microcapsule resistance to chemical and mechanical degradation.Theresults of the study showed that the procedure did not modify microcapsulemembranepermeability and did not affect in vitro and in viva encapsulated cellsurvival.
机译:有人提出在半透膜中进行细胞的免疫分离。防止其在移植后受到免疫破坏的手段[1、2]。然而,在考虑临床之前,有几个基本问​​题尚待解决应用这种方法。这样的问题之一是微胶囊对化学药品的抵抗力和机械降解。强大的微胶囊会明显增加的耐久性移植。它也可能会改善其的长期生物相容性微胶囊,因为强烈的囊周围反应总是在破裂或损坏周围产生胶囊[3,4]。此外,微胶囊膜的强度和耐用性是病毒转染的生物工程移植的关键问题细胞。这些病毒转染的生物工程细胞可能包括产生胰岛素的细胞细胞以及细胞产生促进胰岛细胞的分子存活/复制/转分化或确保胰岛和微胶囊的免疫保护。最后,考虑供应有限在人类胰岛中,最有希望的替代β细胞的方法是干细胞向胰岛的转分化[5](不一定是胚胎干细胞,引起争议,但干细胞有许多其他来源,包括自体细胞)。请注意,即使是自体细胞也需要针对复发自身免疫过程。与这种方法有关的主要问题是的风险未成熟干细胞的恶性转化。微胶囊几乎不能在与生活相适应的条件下被销毁将提供一种安全的方法移植干细胞衍生的细胞,生物工程细胞或永生化的细胞细胞。海藻酸盐和聚阳离子如聚-L-赖氨酸(PLL)之间的络合为的微囊化细胞的最广泛方法[2]。微胶囊是建通过一个简单的三步过程。首先,通话被困在珠子中由...组成通过钙等二价比实现藻酸盐的离子交联[6]。第二步骤包括用聚阳离子(例如PLL)涂覆藻酸盐珠,形式确保良好控制分子量截留的外围膜和增加膜的稳定性。最后,第三步包括藻酸盐溶液的微胶囊,以确保生物相容性。他们俩后面的反应取决于聚阴离子之间的离子相互作用海藻酸盐和聚赖氨酸的多阳离子聚合物[7,8]。为了提高微囊强度,我们[9]和其他人[7,8,10,11],有评估了内在调节对微胶囊强度的影响参数PLL分子量,浓度和孵育时间以及甘露糖醛酸酸/古洛糖醛酸海藻酸的酸比率。通过介绍形成中性胶囊新的还研究了涂层剂[12]。经过这些实验,更紧获得了PLL和藻酸盐之间的结合。尽管如此,聚L-赖氨酸仍然与环境中其他带正电荷的分子竞争以结合的海藻酸盐珠。在高浓度溶液中长时间孵育Ca2 +或Sr2 +已显示出藻酸盐-聚-L-赖氨酸边界的位移[13,14]。此外,周四等。已经观察到海藻酸盐来自微胶囊在几天或几周之内[7]。为了防止与环境中的带电分子竞争,新的提出了一个概念:将共价链接引入膜微胶囊[15-17]。众所周知,共价链接比静电的互动。面临的挑战是,大多数方法可以创建或破坏共价链接是与活细胞的存活不相容。目前的目标工作是为了开发并验证一种与封装的细胞存活率兼容的方法创建一个PLL层与微囊藻酸盐之间的共价连接核心和从外层。这样的微胶囊不太可能是被毁在活体内发现的情况下。在这里,我们表明有可能将活细胞微囊化在膜中由共价连接的藻酸盐-PLL-藻酸盐膜组成,没有影响细胞可行性。两者之间在PLL和藻酸盐之间形成共价链接的海藻酸盐核心和外部海藻酸盐鞋子大大增加了微胶囊抵抗性承受化学和机械应力。标准APA微胶囊溶于45当它们在碱性溶液中孵育时的秒数,而共价链接的APA在相同的碱性溶液中放置两年后,微胶囊保持不变共价连接的微胶囊的抗药性是标准药物的22倍微胶囊受到机械应力时。这个过程是基于可光活化的聚-L-赖氨酸(PLL)的化学衍生异双功能交联剂,N-5-叠氮基-2-硝基苯甲酰氧基琥珀酰亚胺(ANB-NOS),当由UVA光激发时,它能够将PLL与藻酸盐共价结合照明[18,19]。交联的N-羟基琥珀酰亚胺是拳头共价地在可能会损坏活细胞的条件下连接到PLL,但在马驹是参与程序。然后将胰岛细胞包裹在藻酸钙中将微胶囊与玫瑰连接子衍生的PLL孵育,再次藻酸盐化形成外部生物相容性片材。当用紫外线灯的可光活化残基与叠氮苯残基反应海藻酸盐在PLL和藻酸盐之间创建共价链接。后者反应不是对...有害活细胞。所有涉及交联剂衍生的PLL的反应均为在黑暗中表演室,直到UVA照明,以防止激活可光激活的残留物。我们在此提供证明,证明形成了共价键大量改善微胶囊对化学和机械降解的抵抗力。的研究结果表明该程序没有改变微胶囊膜通透性,不影响体外和体内包囊细胞生存。

著录项

  • 公开/公告号CA2437250A1

    专利类型

  • 公开/公告日2005-02-14

    原文格式PDF

  • 申请/专利权人 IMS RECHERCHE INC.;

    申请/专利号CA20032437250

  • 申请日2003-08-14

  • 分类号A61K9/50;A61K35/12;A61K47/42;A61K48/00;A61L27/22;A61L27/38;A61L27/54;

  • 国家 CA

  • 入库时间 2022-08-21 22:14:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号